140 related articles for article (PubMed ID: 21235475)
1. Formulation and evaluation of extended release asymmetric membrane capsules of atenolol.
Guarve K; Gupta GD
Curr Drug Deliv; 2011 Mar; 8(2):159-63. PubMed ID: 21235475
[TBL] [Abstract][Full Text] [Related]
2. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
[TBL] [Abstract][Full Text] [Related]
3. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients.
Thombre AG; DeNoto AR; Gibbes DC
J Control Release; 1999 Aug; 60(2-3):333-41. PubMed ID: 10425338
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric Membrane Capsules for Extended Delivery of the Weakly Basic Drug Carvedilol.
Guarve K; Gupta GD
Pharmaceutics; 2010 May; 2(2):199-208. PubMed ID: 27721351
[TBL] [Abstract][Full Text] [Related]
5. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
[TBL] [Abstract][Full Text] [Related]
7. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice.
Lin YK; Ho HO
J Control Release; 2003 Apr; 89(1):57-69. PubMed ID: 12695063
[TBL] [Abstract][Full Text] [Related]
8. The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine.
Nie S; Pan W; Li X; Wu X
Drug Dev Ind Pharm; 2004 Jul; 30(6):627-35. PubMed ID: 15285336
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
[TBL] [Abstract][Full Text] [Related]
10. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
11. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
[TBL] [Abstract][Full Text] [Related]
12. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
Khan ZA; Tripathi R; Mishra B
AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
[TBL] [Abstract][Full Text] [Related]
13. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
14. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
[TBL] [Abstract][Full Text] [Related]
15. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
16. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
17. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
[TBL] [Abstract][Full Text] [Related]
18. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
19. Preparation of lovastatin matrix sustained-release pellets by extrusion-spheronization combined with microcrystal dispersion technique.
He H; Shi B; Cai C; Tang X
Arch Pharm Res; 2011 Nov; 34(11):1931-8. PubMed ID: 22139692
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro evaluation of prolonged release floating microspheres of atenolol using multicompartment dissolution apparatus.
Bhadouriya P; Kumar M; Pathak K
Drug Dev Ind Pharm; 2013 Nov; 39(11):1663-71. PubMed ID: 23062186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
